Trial Profile
Study of changes in natalizumab treatment patterns and association with relapse outcomes in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 13 Oct 2014 New trial record